Histotripsy for liver cancer: What to know about this novel cancer treatment 
Liver Fibrosis Treatment Market Valuation is Set to Reach 
Blood vessel-like coating could make medical devices safer for patients 
DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health 
Liver Cancer Treatment Breakthrough in Global Study 
Introducing the NBCA Advocacy Institute
July 10, 2024 To put an end to the 100,000 deaths each year to blood clots, the National Blood Clot...
Using hyperhomocysteinemia and body composition to predict the risk of non-alcoholic fatty liver disease in healthcare workers
1. IntroductionThe prevalence of NAFLD is approximately 25%, and continues to rise along with global obesity rates (1, 2). NALFD,...
Calyxo Announces New ASPIRE 1-Year Study Results
Calyxo, Inc., a medical device company developing innovative solutions for patients with kidney stones, has announced positive new study results...
National Blood Clot Alliance Appoints Healthcare Veteran Erin VanDyke as Vice President, VTE Centers of Excellence
PHILADELPHIA, Aug. 22, 2024 /PRNewswire/ --Â The National Blood Clot Alliance www.stoptheclot.org, the nation's leading patient advocacy organization dedicated to advancing...
Factors associated with chronic kidney disease in patients with diabetes in French Guiana
1 IntroductionDiabetes is a major public health problem. The prevalence of diabetes continues to increase worldwide, mainly in developing countries....
Is End-Stage Renal Disease Treatment Choices Model Moving the Needle?
A recent JAMA Health Forum study found that the Centers for Medicare & Medicaid Services’ End-Stage Renal Disease Treatment Choices...